Please login to the form below
The Editors blog
An inside look at what’s happening within the pharma industry and across the PMGroup from the PMLiVE editorial team
PMLiVE: revitalised and refreshed
A 'beta' phase unveiling for our website's new look
We've been working on this project for some time and now it's time to welcome you to the new-look PMLiVE.
There have been some significant changes to the site in the year since I joined PMGroup, among them the Digital Intelligence blog, a greater focus on people news and a series of refinements to how we approach online publishing.
And now we hope that the site's clean new design will bring out the best from in all this work.
But a word of caution, we wanted you to see the site as soon as possible. So, for now, we're still in a 'beta' phase, which means there may be one or two things that aren't quite in their final version.
While we make sure everything's working as expected we'd love to have your feedback on the refreshed site – you can contact us directly or leave a comment below.
By Dominic Tyer, managing editor - PME & PMLiVE
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
